Fierce Biotech News & Reports
WEB5 days ago · Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
Biotech | Fierce Biotech
WEBFeb 12, 2024 · After a small downsizing this summer, Relay is now shedding about 10% of its workforce. Gabrielle Masson Oct 3, 2024 4:23pm. Connect. The Team. Advertise. Join Us. Newsletters. Resources. RSS Feeds.
Gabrielle Masson - Fierce Biotech
WEBGabrielle Masson is an associate editor for Fierce Biotech. Prior to Fierce, she worked at Becker's Hospital Review, where she reported on public health and the pandemic. Gabrielle graduated from ...
MedTech | Fierce Biotech
WEB5 days ago · Proscia said its new offerings are aimed at healthcare organizations and research institutions that aim to wield their massive, proprietary datasets. Conor Hale Oct 3, 2024 1:45pm. Connect. The Team.
Grail delivers final study results showing its blood test's accuracy in ...
WEBJun 25, 2021 · The final results from a Grail study of its cancer-tracing blood test found it was accurate at detecting a range of different tumors at early stages—especially those more likely to be lethal and ha
Bristol Myers pays $800M upfront for antibody-drug conjugate
WEBDec 12, 2023 · Bristol Myers Squibb has filled the antibody-drug conjugate (ADC) shaped hole in its pipeline by following the increasingly well-trodden path to China, handing SystImmune $800 million upfront for ...
BMS plans $1.5B in cuts through '25, with 2,000-plus layoffs
WEBApr 25, 2024 · Bristol Myers Squibb is the latest large pharma to wield the restructuring ax, with plans to cut $1.5 billion in costs by the end of 2025, including laying off more than 2,000 employees.
Altos bursts out of stealth with $3B, a dream team C-suite and a …
WEBJan 19, 2022 · RELATED: Barron quits GSK to take CEO post at $3B biotech startup The team will use $3 billion in capital committed by investors including Arch Venture Partners to try to turn breakthroughs in our ...
Regeneron to fill gaps in obesity, break ground in cell therapy
WEBFeb 2, 2024 · Regeneron wants to fill the gaps in care with a combo approach from its pipeline, adding trevogrumab or garetosmab to semaglutide (Wegovy) to improve the quality of weight loss that patients ...
Regeneron plans $1.8B upgrade at Tarrytown campus ... - Fierce …
WEBJul 16, 2021 · The Empire State's biggest biotech Regeneron Pharmaceuticals is plotting a hefty investment to beef up R&D in Tarrytown. | Regeneron laid plans for a six-year, $1.8 billion expansion at its ...